Mirexia Xr Tablet 25mg

Mirexia XR Tablet 25mg contains the active ingredient Mirabegron . Mirabegron is a medication used primarily for the treatment of overactive bladder (OAB) symptoms, such as urinary urgency, frequency, and urge incontinence. It belongs to a class of drugs known as beta-3 adrenergic receptor agonists. Mirexia XR is an extended-release formulation, which means it releases the medication gradually over an extended period, providing sustained therapeutic effects.

Uses:

1. Overactive Bladder (OAB): Mirexia XR Tablet 25mg is indicated for the management of symptoms associated with overactive bladder, including urinary urgency, frequency, and urge incontinence. By stimulating beta-3 adrenergic receptors in the bladder, Mirabegron helps relax bladder muscles, increase bladder capacity, and improve control over urination.

Side Effects:

While Mirexia XR Tablet 25mg is generally well-tolerated, it may cause side effects in some individuals. Common side effects associated with Mirabegron include:

• Increased Blood Pressure: Mirabegron may cause a slight increase in blood pressure in some patients. Blood pressure should be monitored regularly, especially in patients with hypertension.
• Urinary Tract Infections (UTIs): Some patients may experience urinary tract infections while taking Mirexia XR Tablet. Symptoms of UTIs include painful or frequent urination, urgency, and lower abdominal discomfort.
• Headache: Headaches are a common side effect of Mirabegron and are usually mild and transient.
• Constipation: Constipation may occur in some individuals while taking Mirexia XR Tablet. Maintaining adequate hydration and dietary fiber intake can help alleviate this symptom.

Precautions:

• Cardiovascular Disease: Patients with a history of cardiovascular disease should use Mirexia XR Tablet 25mg with caution, as Mirabegron may cause increases in blood pressure and heart rate.
• Liver or Kidney Impairment: Individuals with liver or kidney impairment should use Mirabegron cautiously, as dosage adjustments may be necessary to prevent adverse effects.
• Urinary Retention: Mirabegron should be used with caution in patients with bladder outlet obstruction or urinary retention, as it may exacerbate these conditions.
• Pregnancy and Breastfeeding: The safety of Mirexia XR Tablet 25mg during pregnancy and breastfeeding has not been established. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.